Harald Hjelde

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten et al. · Journal of Clinical Oncology · 2009 · 290 citations · Full text

Medicine, Oncology, Pharmacology +16

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

Guro B. Stene, Jorunn L. Helbostad, Tore Amundsen et al. · Acta Oncologica · 2014 · 215 citations · Full text

Medicine, Oncology, Radiology +17

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy

Bjørn Henning Grønberg, Stein Sundstrøm, Stein Kaasa et al. · European Journal of Cancer · 2010 · 120 citations

Medicine, Oncology, Chemotherapy +15

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

Nina Helbekkmo, Stein Sundstrøm, Ulf Aasebø et al. · British Journal of Cancer · 2007 · 77 citations · Full text

Medicine, Oncology, Pharmacology +16

Measurement of health-related quality of life during chemotherapy – the importance of timing

Are Kristensen, Tora S. Solheim, Tore Amundsen et al. · Acta Oncologica · 2017 · 18 citations · Full text

Medicine, Oncology, Pharmacology +11